Original Article
Lymph node metastasis-related lncRNA GAS6-AS1 facilitates the progression of esophageal squamous cell carcinoma
Journal of Gastrointestinal Oncology
2023;
14
(6)
:2293-2308
.
(27 December 2023)
Comparison of clinicopathological features and survival analysis between esophageal neuroendocrine carcinoma and esophageal squamous cell carcinoma based on the SEER database, alongside nomogram analysis for esophageal neuroendocrine carcinoma
Journal of Gastrointestinal Oncology
2023;
14
(6)
:2309-2323
.
(27 December 2023)
Effect of ramucirumab plus paclitaxel in advanced gastric cancer according to the status of programmed cell death-ligand 1 (PD-L1) expression
Journal of Gastrointestinal Oncology
2023;
14
(6)
:2324-2333
.
(27 December 2023)
Risk factors for remnant gastric cancer after distal gastrectomy for gastric cancer: a retrospective database review
Journal of Gastrointestinal Oncology
2023;
14
(6)
:2334-2345
.
(27 December 2023)
The role of ramucirumab plus paclitaxel as second-line therapy after failure of nivolumab plus doublet chemotherapy in patients with advanced gastric cancer
Journal of Gastrointestinal Oncology
2023;
14
(6)
:2346-2353
.
(27 December 2023)
A methylation-related signature for predicting prognosis and sensitivity to first-line therapies in gastric cancer
Journal of Gastrointestinal Oncology
2023;
14
(6)
:2354-2372
.
(27 December 2023)
Development and validation of a nomogram to predict pathological complete response in patients with locally advanced gastric adenocarcinoma treated with neoadjuvant chemotherapy in combination with PD-1 antibodies
Journal of Gastrointestinal Oncology
2023;
14
(6)
:2373-2383
.
(27 December 2023)
Prospective observational study of zinc deficiency symptoms during first-line chemotherapy for gastric and colorectal cancer
Journal of Gastrointestinal Oncology
2023;
14
(6)
:2384-2394
.
(27 December 2023)
Prognostic value of the ratio of pretreatment carcinoembryonic antigen to tumor volume in rectal cancer
Journal of Gastrointestinal Oncology
2023;
14
(6)
:2395-2408
.
(27 December 2023)
Effect of low-level creatinine clearance on short-term postoperative complications in patients with colorectal cancer
Journal of Gastrointestinal Oncology
2023;
14
(6)
:2409-2424
.
(27 December 2023)
Efficacy, safety, and predictors of fruquintinib plus anti-programmed death receptor-1 (PD-1) antibody in refractory microsatellite stable metastatic colorectal cancer in a real-world setting: a retrospective cohort study
Journal of Gastrointestinal Oncology
2023;
14
(6)
:2425-2435
.
(27 December 2023)
Protective effects of palbociclib on colitis-associated colorectal cancer
Journal of Gastrointestinal Oncology
2023;
14
(6)
:2436-2447
.
(27 December 2023)
CYP1B1 promotes colorectal cancer liver metastasis by enhancing the growth of metastatic cancer cells via a fatty acids-dependent manner
Journal of Gastrointestinal Oncology
2023;
14
(6)
:2448-2465
.
(27 December 2023)
Patterns and kinetics of hepatocellular carcinoma relapse post-liver transplantation: oligorecurrence and role of local therapies
Journal of Gastrointestinal Oncology
2023;
14
(6)
:2466-2478
.
(27 December 2023)
ACTB may serve as a predictive marker for the efficacy of lenvatinib in patients with HBV-related early-stage hepatocellular carcinoma following partial hepatectomy: a retrospective cohort study
Journal of Gastrointestinal Oncology
2023;
14
(6)
:2479-2499
.
(27 December 2023)
Perineural invasion confers poorer clinical outcomes in patients with T1/T2 intrahepatic cholangiocarcinoma: a single center, retrospective cohort study
Journal of Gastrointestinal Oncology
2023;
14
(6)
:2500-2510
.
(27 December 2023)
The prognostic value of the number of metastatic lymph nodes on the long-term survival of intrahepatic cholangiocarcinoma using the SEER database
Journal of Gastrointestinal Oncology
2023;
14
(6)
:2511-2520
.
(27 December 2023)
Comparison of the effects of sufentanil-dominant anaesthesia/analgesia and epidural anaesthesia/analgesia on postoperative immunological alterations, stress responses and prognosis in open hepatectomy: a randomized trial
Journal of Gastrointestinal Oncology
2023;
14
(6)
:2521-2535
.
(27 December 2023)
Efficacy and safety of regorafenib as second-line treatment for patients with hepatocellular carcinoma and macrovascular invasion and(or) extrahepatic metastasis
Journal of Gastrointestinal Oncology
2023;
14
(6)
:2536-2548
.
(27 December 2023)
Efficacy and safety of regorafenib in combination with immune checkpoint inhibitor therapy as second-line and third-line regimen for patients with advanced hepatocellular carcinoma: a retrospective study
Journal of Gastrointestinal Oncology
2023;
14
(6)
:2549-2558
.
(27 December 2023)
Identification of potential prognostic biomarkers among gene models for coiled-coil domain-containing family members in hepatocellular carcinoma elucidates their influence on the hypoxia pathway and immune microenvironment
Journal of Gastrointestinal Oncology
2023;
14
(6)
:2559-2573
.
(27 December 2023)
Identification of acetylshikonin as a novel tubulin polymerization inhibitor with antitumor activity in human hepatocellular carcinoma cells
Journal of Gastrointestinal Oncology
2023;
14
(6)
:2574-2586
.
(27 December 2023)
Oncological role of surgical resection in patients with pancreatic ductal adenocarcinoma with liver-only synchronous metastases in a single-center retrospective study
Journal of Gastrointestinal Oncology
2023;
14
(6)
:2587-2599
.
(27 December 2023)
Review Article
A narrative review of the evolving landscape of the management of metastatic gastric cancer: the role of targeted therapies
Journal of Gastrointestinal Oncology
2023;
14
(6)
:2600-2616
.
(27 December 2023)
Case Report: iMDT Corner
Significant response from fruquintinib plus anti-PD-1 immunotherapy for microsatellite stable metastatic colorectal cancer with liver and lung metastasis in the third line: case report
Journal of Gastrointestinal Oncology
2023;
14
(6)
:2617-2626
.
(27 December 2023)
Case Report
Postpartum related intrahepatic cholangiocarcinoma with FGFR2 fusion and severe hyperbilirubinemia with response to FGFR inhibitor pemigatinib: case report and review
Journal of Gastrointestinal Oncology
2023;
14
(6)
:2627-2636
.
(27 December 2023)
Durable response to first-line PARP inhibition in BRCA-mutated metastatic cholangiocarcinoma: case report
Journal of Gastrointestinal Oncology
2023;
14
(6)
:2637-2643
.
(27 December 2023)
Immunotherapy before liver transplant in unresectable hepatocellular carcinoma: a case report
Journal of Gastrointestinal Oncology
2023;
14
(6)
:2644-2649
.
(27 December 2023)
Two families with gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): case reports and literature review
Journal of Gastrointestinal Oncology
2023;
14
(6)
:2650-2657
.
(27 December 2023)
Camrelizumab and apatinib combined with chemotherapy in perioperative effective therapy for advanced gastric carcinoma with peritoneal metastasis: a case report
Journal of Gastrointestinal Oncology
2023;
14
(6)
:2658-2667
.
(27 December 2023)
Editorial
Exploring HMGB2 in hepatocellular carcinoma: charting new paths for diagnostic and therapeutic innovations
Journal of Gastrointestinal Oncology
2023;
14
(6)
:2668-2670
.
(27 December 2023)
Letter to the Editor
The efficacy and safety of endoscopic mucosal dissection for early gastrointestinal cancer and precancerous lesions
Journal of Gastrointestinal Oncology
2023;
14
(6)
:2671-2672
.
(27 December 2023)
